{"id":"W4295508751","doi":"10.1038/s41587-022-01451-7","title":"Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD","year":2022,"lang":"en","type":"article","venue":"Nature Biotechnology","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Arnold Ventures; Blue Cross Blue Shield of Massachusetts","keywords":"Nebulizer; Business; COPD; Dominance (genetics); Asthma; Marketing; Brand names; Competition (biology); Advertising; Medicine; Anesthesia; Chemistry; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002189719,0.0001367271,0.0002523583,0.0002691942,0.0002311494,0.000007565946,0.0001044367,0.0006105325,0.0006821663],"category_scores_gemma":[0.0001016891,0.000111706,0.00007020603,0.000262597,0.00008338513,0.00002145089,0.0001234271,0.0007255519,0.000007588291],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007654346,"about_ca_system_score_gemma":0.00005707601,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003133897,"about_ca_topic_score_gemma":0.000003304532,"domain_scores_codex":[0.9991126,0.00004677819,0.000135224,0.0003361793,0.0001516076,0.0002176008],"domain_scores_gemma":[0.9994794,0.00006672261,0.00004563138,0.0002779111,0.00005711008,0.00007327981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007208697,0.0005242559,0.001811122,0.0001318155,0.0001408505,0.0001543773,0.0004039421,0.00001094621,0.2184681,0.007412879,0.3386446,0.4250884],"study_design_scores_gemma":[0.003267016,0.001010103,0.001463977,0.000006728984,0.00001480793,0.0001676509,0.0001032169,0.0001149994,0.02562108,0.00008968006,0.9680034,0.0001373247],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9438684,0.005788391,0.0002734048,0.04596591,0.0005123048,0.001269642,0.00008410112,0.0002887678,0.001949063],"genre_scores_gemma":[0.9789556,0.0001517999,0.0008637267,0.01538411,0.0001405456,0.0001181501,0.00002165206,0.00002769284,0.004336719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6293588,"threshold_uncertainty_score":0.7469242,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008984173584401766,"score_gpt":0.2751956174091393,"score_spread":0.2662114438247375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}